Cellectis (CLLS) Misses Q4 EPS by 7c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• BNP Paribas Exane Starts Klepierre (LI:FP) (KLPEF) at Neutral
• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Williams Companies (WMB) PT Lowered to $85 at Jefferies